I have stage IV renal cell carcinoma and I’m surprisingly content
Joel Stern on how to take a dire diagnosis and make the best of it.
Joel Stern on how to take a dire diagnosis and make the best of it.
KCA’s Medical Director Sallie McAdoo featured on the Cancer Interviews podcast.
This is a guest post by Jason Hinojosa, a marketing professional, new father, and kidney cancer patient based in Seattle, Washington. He is also a KCA Ambassador. It was your typical Super Bowl Sunday, people…
Dr. Nirmish Singla received a 2021 Young Investigator Award for his project “Tumor evolution of brain-specific tropism in metastatic renal cell carcinoma.” Singla is based at Johns Hopkins University in Baltimore, Maryland. We spoke with…
Dr. Eric Kauffman received a 2021 Young Investigator Award for his project “Biology of spontaneously regressing renal cell carcinoma primary tumors.” Kauffman is based at the Roswell Park Comprehensive Cancer Center in Buffalo, New York….
Dr. Elshad Hasanov received a 2021 Young Investigator Award for his project “Investigating genomic drivers of immune checkpoint inhibitors resistance in RCC brain metastasis: implications for immunotherapy.” Hasanov is based at the MD Anderson Cancer…
Dr. Yuexin Xu received a 2021 Young Investigator Award for her project “Transcriptomic single-cell and spatial mapping of immune cell infiltration and tumor-associated endothelial cell heterogeneity in renal cell carcinoma.” Xu is based at the…
Dr. Jianjun Gao and Dr. Pavlos Msaouel received a 2021 Advanced Discovery Award for their project “Identification of tumor frameshift neoantigens to accurately predict response to immune checkpoint therapy in renal cell carcinoma.” Both Gao…
Dr. Cristiane Bergerot received a 2021 Focus Award: Psychosocial for her project “Redefining Quality of Life Assessments in Metastatic Renal Cell Carcinoma.” Bergerot is based at the Instituto Unity de Ensino e Pesquisa, Centro De…
Dr. Toni Choueiri and Dr. Rizwan Romee received a 2021 Advanced Discovery Award for their project “Adoptive cytokine-induced memory-like NK cell therapy alone or in combination with avelumab for immunotherapy-refractory advanced renal cell carcinoma.” Both…